SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-082637
Filing Date
2024-07-25
Accepted
2024-07-25 16:15:10
Documents
17
Period of Report
2024-07-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2420145d1_8k.htm   iXBRL 8-K 29396
2 EXHIBIT 10.1 tm2420145d1_ex10-1.htm EX-10.1 19265
3 EXHIBIT 10.2 tm2420145d1_ex10-2.htm EX-10.2 67336
7 GRAPHIC tm2420145d1_ex10-2img001.jpg GRAPHIC 6772
8 GRAPHIC tm2420145d1_ex10-2img002.jpg GRAPHIC 5496
  Complete submission text file 0001104659-24-082637.txt   326689

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA armp-20240722.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20240722_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20240722_pre.xml EX-101.PRE 22367
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2420145d1_8k_htm.xml XML 3547
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 241142241
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)